XBiotech, Inc. (XBIT)
2.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
2.20
0.00 (0.00%)
After-Hours: 20:00
XBiotech Total Assets (Quarterly) : 133.65M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 133.65M |
| March 31, 2026 | 139.84M |
| December 31, 2025 | 150.26M |
| September 30, 2025 | 172.42M |
| June 30, 2025 | 178.68M |
| March 31, 2025 | 181.86M |
| December 31, 2024 | 199.09M |
| September 30, 2024 | 209.85M |
| June 30, 2024 | 215.56M |
| March 31, 2024 | 227.86M |
| December 31, 2023 | 227.24M |
| September 30, 2023 | 229.60M |
| June 30, 2023 | 235.14M |
| March 31, 2023 | 242.12M |
| December 31, 2022 | 247.76M |
| September 30, 2022 | 250.83M |
| June 30, 2022 | 266.46M |
| March 31, 2022 | 270.80M |
| December 31, 2021 | 276.27M |
| September 30, 2021 | 279.52M |
| June 30, 2021 | 353.96M |
| March 31, 2021 | 355.94M |
| December 31, 2020 | 354.50M |
| September 30, 2020 | 353.39M |
| June 30, 2020 | 358.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 358.37M |
| December 31, 2019 | 817.32M |
| September 30, 2019 | 66.64M |
| June 30, 2019 | 71.88M |
| March 31, 2019 | 39.82M |
| December 31, 2018 | 44.34M |
| September 30, 2018 | 49.24M |
| June 30, 2018 | 54.29M |
| March 31, 2018 | 58.86M |
| December 31, 2017 | 62.97M |
| September 30, 2017 | 70.67M |
| June 30, 2017 | 77.84M |
| March 31, 2017 | 87.62M |
| December 31, 2016 | 67.05M |
| September 30, 2016 | 78.29M |
| June 30, 2016 | 93.20M |
| March 31, 2016 | 101.26M |
| December 31, 2015 | 109.36M |
| September 30, 2015 | 119.05M |
| June 30, 2015 | 126.85M |
| March 31, 2015 | 58.69M |
| December 31, 2014 | 62.18M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.19M |
| Shareholders Equity (Quarterly) | 128.46M |
| Current Ratio | 33.15 |